Potential approaches for the pricing of cancer medicines across Europe to enhance the sustainability of healthcare systems and the implications



Godman, Brian, Hill, Andrew, Simoens, Steven, Selke, Gisbert, Selke Krulichova, Iva, Zampirolli Dias, Carolina, Martin, Antony P ORCID: 0000-0003-4383-6038, Oortwijn, Wija, Timoney, Angela, Gustafsson, Lars L
et al (show 40 more authors) (2021) Potential approaches for the pricing of cancer medicines across Europe to enhance the sustainability of healthcare systems and the implications. EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH.

[img] Text
Godman_2021_Cancer-drug-pricing-Europe- Accepted-for-publication.pdf - Accepted Version
Access to this file is embargoed until 4 February 2022.

Download (386kB)
Item Type: Article
Uncontrolled Keywords: Alternative pricing approaches, cancer medicines, europe, managed entry agreements, multicriteria decision analyses, minimum effectiveness criteria, payers, transparent pricing approaches, tiered pricing approaches
Depositing User: Symplectic Admin
Date Deposited: 17 Feb 2021 14:36
Last Modified: 03 May 2021 16:11
DOI: 10.1080/14737167.2021.1884546
Related URLs:
URI: https://livrepository.liverpool.ac.uk/id/eprint/3115771